INVESTING IN THE FUTURE OF CANNABIS
Investors:
Overview
Stock
Financial Reports
Regulatory Filings
Governance
Analysts
Email Alerts
Press Releases
Email Alerts
Year
All Years
2021
2020
2019
2018
2017
2016
Keywords
Go
Advanced Search
Search
Search Headlines Only
From
To
Asset Types
Photos
Video
Audio
Documents
Events
Standard
Dec 18, 2020
PharmaCielo Announces Appointment of Caroline Lenardon for Expansion of Retail Investor Relations Capacity
Dec 11, 2020
PharmaCielo Enters Strategic Alliance to Provide Pre-Tested and Insured Product to Customers in the U.S. Market
Dec 7, 2020
PharmaCielo Receives Approximately CDN$3.0 Million in Non-Dilutive Funding from Colombian State-Owned Banco Agrario
Dec 3, 2020
PharmaCielo Welcomes Landmark United Nations Decision to Remove Cannabis from Narcotic Drugs List
Dec 2, 2020
PharmaCielo Announces Grant of Stock Options
Nov 30, 2020
PharmaCielo Announces Financial Results for the Third Quarter Ended September 30, 2020
Nov 30, 2020
PharmaCielo Ltd. Announces New Leadership
Nov 25, 2020
PharmaCielo Achieves Good Agricultural and Collection Practices (GACP) Designation
Nov 23, 2020
PharmaCielo Announces Closing of $10M Private Placement
Nov 19, 2020
PharmaCielo Mexico Salutes Mexican Senate for Advancing Cannabis Legalization
Nov 18, 2020
PharmaCielo Enters U.K. Market with 500kg Initial Shipment to Established Manufacturer and Distributor - Reaches 2021 Agreement
Nov 16, 2020
PharmaCielo to Hold Conference Call to Review Third Quarter 2020 Financial Results
Nov 13, 2020
PharmaCielo to Participate in 2020 Cowen Boston Cannabis Conference
Nov 5, 2020
PharmaCielo Begins Harvest of High-THC Cultivars for Extract Export
Photos
1
Nov 3, 2020
PharmaCielo Announces Upsizing of Private Placement Offering
Nov 2, 2020
PharmaCielo Ltd. Expands Board Depth and Expertise with Appointment of Marc Lustig as Lead Director and Strengthens Capital Position with Private Placement Offering
Oct 23, 2020
PharmaCielo to Participate in Cantor Fitzgerald Latin America Cannabis Seminar
Sep 22, 2020
PharmaCielo Declared 'Project of National Strategic Interest' by Government of Colombia
Sep 21, 2020
PharmaCielo Expands Portfolio of Cannabis Extracts to Meet Global B2B Medical-Grade Market Demand
Aug 31, 2020
PharmaCielo Announces Financial Results for the Second Quarter Ended June 30, 2020 and Provides Operational Update
Aug 18, 2020
PharmaCielo to Hold Conference Call to Review Second Quarter 2020 Financial Results
Aug 13, 2020
PharmaCielo Increases Cannabis Cultivation Through External Contractor to Meet Market Demand for Medicinal Extracts
Aug 7, 2020
PharmaCielo Announces Results of AGM
Jul 8, 2020
PharmaCielo Receives Colombian Government Authorization for 10 Tonnes of High-THC Cultivation and Extract Production for Export
Jul 3, 2020
PharmaCielo Ltd. Closes $4.6 Million Bought Deal Offering
Jun 29, 2020
PharmaCielo Ltd. Files Final Prospectus for $4 Million Bought Deal Offering
Jun 10, 2020
PharmaCielo Ltd. Announces $4,000,000 Bought Deal Public Offering
Jun 1, 2020
PharmaCielo Announces Financial Results for the First Quarter Ended March 31, 2020 and Provides Operational Update
May 15, 2020
PharmaCielo Ltd. Obtains Final Receipt for Short Form Prospectus
May 12, 2020
PharmaCielo Welcomes Dr. Claudia Jiménez to Board of Directors
May 4, 2020
PharmaCielo Adds Experienced Senior Leader to Executive Team
Apr 30, 2020
PharmaCielo Announces Financial Results for the Fourth Quarter and Fiscal Year Ended December 31, 2019
Apr 29, 2020
PharmaCielo Provides Details for Fourth Quarter and Year-End 2019 Results Conference Call
Apr 15, 2020
PharmaCielo Ltd. Announces Closing of Previously Announced $8 Million Private Placement Financing
Apr 6, 2020
PharmaCielo Ltd. Prices $8 Million Offering; Closing Scheduled for April 14
Apr 1, 2020
PharmaCielo Ltd. Announces Best Efforts Private Placement Offering
Mar 23, 2020
PharmaCielo Independent Investigation Concludes Short-seller Report Contains Accusations and Claims based on Faulty Interpretation of Events and Information
Mar 3, 2020
PharmaCielo Issues Statement Regarding Misleading Short Seller Report
Jan 27, 2020
PharmaCielo Announces 30,000 Kg Cannabis Extract Agreement for German Market
Jan 24, 2020
PharmaCielo Signs Pan-European Distribution Agreement for CBD Isolate and Broad-Spectrum CBD Oil
Jan 22, 2020
PharmaCielo Added to XCAN - the Newly Created S&P/TSX Cannabis Index
Jan 20, 2020
PharmaCielo Becomes First Cultivator Awarded Good Agricultural Practices (GAP) Global Certification for Colombian Medicinal-Cannabis Operations
Photos
1
Jan 17, 2020
PharmaCielo Receives Acceptance from TSX Venture Exchange of Supply Agreement for Export of 2018 Farm Bill-Compliant CBD Isolate to United States
Dec 14, 2019
PharmaCielo Awarded Game-Changer Award by MJDaily
Dec 5, 2019
PharmaCielo Announces Receipt of CAD$3.9 Million Secured Loan Repayment
Dec 2, 2019
PharmaCielo Graduates to OTCQX® Best Market and Secures DTC Eligibility
Nov 25, 2019
PharmaCielo to Hold Conference Call to Review Third Quarter 2019 Financial Results
Nov 25, 2019
PharmaCielo Announces Financial Results for the Three and Nine Months Ended September 30, 2019
Nov 8, 2019
PharmaCielo Announces RSU Grant
Nov 5, 2019
PharmaCielo Announces Termination of Scheme Implementation Agreement with Creso Pharma
Show
5
10
25
50
100
per page
«
1
2
3
»
